Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters

This study has been completed.
Sponsor:
Information provided by:
University Hospital Orebro
ClinicalTrials.gov Identifier:
NCT00678314
First received: May 13, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted

May 13, 2008
May 13, 2008
January 2004
January 2006   (final data collection date for primary outcome measure)
This study was done with the primary aim of assessing the efficacy (as calculated by pain intensity difference) of patient controlled regional analgesia (PCRA) technique against oral analgesics, which has been the standard of care at our hospital. [ Time Frame: 24 h ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Secondary objectives were to analyze the volume and dose of LA that should be given, patient satisfaction and the long-term outcome for patients treated with the PCRA technique. [ Time Frame: Up to 1 yr after surgery ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters
Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters

This study was done with the primary aim of assessing the efficacy (as calculated by pain intensity difference) of patient controlled regional analgesia (PCRA) technique against oral analgesics, which has been the standard of care at our hospital. Secondary objectives were to analyze the volume and dose of LA that should be given, patient satisfaction and the long-term outcome for patients treated with the PCRA technique.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Carpal Tunnel Syndrome
  • Drug: Ropivacaine 0.2%
    10 ml
  • Drug: Ropivacaine 0.75%
    3 ml
  • Drug: Normal saline
    10 ml
  • Active Comparator: Group A
    Intervention: Drug: Ropivacaine 0.2%
  • Active Comparator: Group B
    Intervention: Drug: Ropivacaine 0.75%
  • Placebo Comparator: Group C
    Intervention: Drug: Normal saline
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
February 2006
January 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with clinically established carpel tunnel syndrome
  • Surgery performed under local anesthesia

Exclusion Criteria:

  • Chronic pain requiring analgesics
Both
18 Years to 75 Years
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT00678314
LMV 151:2003/9759
Yes
Dr Kurt Pettersson, Institution for Clinical Medicine
University Hospital Orebro
Not Provided
Principal Investigator: Kurt Pettersson, MD, PhD Institution for Clinical Medicine
University Hospital Orebro
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP